Yin et al. reported an AUC of 0.85 using a CT radiomics model in 172 HCC patients treated with TACE, programmed cell death protein 1 inhibitors, and tyrosine kinase inhibitors [12]. Here, PDCD1 is linked to hepatocellular carcinoma.